Summary
88 / 100 · Bulios Score
What speaks for it
- Out of every 100 CAD of revenue, 33 CAD is left as net profit.
- Revenue grew by 38% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $7.61M in the last fiscal year, 4.6% of its market value.
What to watch
- Its last loss-making year was 3 years ago.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 2.8 CAD for 1 CAD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (CAD)
Diluted EPS (CAD)
- Analyst estimate
Revenue fell by 19% a year over 5 years. Over the last 3 years it grew by 38% a year.
Growth in detailDoes it make money?
Very wellWhere 100 CAD of revenue goes
- Cost of sales 68 CAD
- Research and development 0.3 CAD
- Sales and administration 5.0 CAD
- Taxes and other -6.2 CAD
- Net profit 33 CAD
Net profit, industry median (Financial - Capital Markets) 23 CAD
Out of every 100 CAD of revenue, 33 CAD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.